CLS-103 Cells from Cytion GmbH

Description

The CLS-103 cell line originates from primary squamous cell carcinoma tumors in NMRI mice. This cell line was developed following the induction of these tumors through a single oral application of 7,12-dimethyl-benz(a)anthracene (DMBA), a potent carcinogen commonly used in experimental cancer research. The choice of DMBA for tumor induction reflects its effectiveness in mimicking human cancer pathways, thereby making the CLS-103 cell line a valuable model for studying the molecular and cellular mechanisms of squamous cell carcinoma

Product Specs
ItemCLS-103 Cells
CompanyCytion GmbH
Price $800.00Supplier Page View Company Product Page
Catalog Number400176
Quantityone cryovial
DiseaseSquamous cell carcinoma
TissueStomach
TypeCell Line
SpeciesMouse
AgeUnspecified
Breed / StrainNMRI
GenderUnspecified
StorageFor long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen
SterilityMycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections
Regulatory StatusOur cells are provided for in vitro laboratory research purposes exclusively and are not intended for clinical or diagnostic use, nor are they to be administered to humans or used for veterinary purposes. Users must adhere to all applicable guidelines and regulations for the handling and use of these cells in a research setting